↓ Skip to main content

Targeting connexin 43 with α–connexin carboxyl-terminal (ACT1) peptide enhances the activity of the targeted inhibitors, tamoxifen and lapatinib, in breast cancer: clinical implication for ACT1

Overview of attention for article published in BMC Cancer, April 2015
Altmetric Badge

Citations

dimensions_citation
54 Dimensions

Readers on

mendeley
41 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Targeting connexin 43 with α–connexin carboxyl-terminal (ACT1) peptide enhances the activity of the targeted inhibitors, tamoxifen and lapatinib, in breast cancer: clinical implication for ACT1
Published in
BMC Cancer, April 2015
DOI 10.1186/s12885-015-1229-6
Pubmed ID
Authors

Christina L Grek, Joshua Matthew Rhett, Jaclynn S Bruce, Melissa A Abt, Gautam S Ghatnekar, Elizabeth S Yeh

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 41 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 2%
Unknown 40 98%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 11 27%
Student > Ph. D. Student 11 27%
Student > Master 4 10%
Researcher 4 10%
Student > Doctoral Student 2 5%
Other 2 5%
Unknown 7 17%
Readers by discipline Count As %
Agricultural and Biological Sciences 10 24%
Biochemistry, Genetics and Molecular Biology 9 22%
Psychology 3 7%
Nursing and Health Professions 2 5%
Immunology and Microbiology 2 5%
Other 8 20%
Unknown 7 17%